Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02882048 · ClinicalTrials.gov registry record · NA

Auricular Acupuncture to Facilitate Outpatient Opioid Weaning

A NA study, sponsored by Vanderbilt University Medical Center.

Terminated
Registry status
NA
Development phase
16
Enrollment target

NCT02882048 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02882048, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.

TERMINATED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study is to compare two groups undergoing opioid weaning as ordered by their referring physicians. One group will undergo the standard opioid weaning process and the other group will have the addition of the NADA Protocol to the weaning process.

Interventions

  • OTHER Medication management
  • PROCEDURE NADA Protocol

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2016-09
Est. Completion 2019-02-25
Phase NA

What the Registry Record Tells You About NCT02882048

The ClinicalTrials.gov registry entry for NCT02882048 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Medication management is the first listed.

NCT02882048 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02882048 about?

NCT02882048 is a clinical study titled "Auricular Acupuncture to Facilitate Outpatient Opioid Weaning". This study is to compare two groups undergoing opioid weaning as ordered by their referring physicians. One group will undergo the standard opioid weaning process and the other group will have the addition of the NADA Protocol to the weaning process.

What is the current status of trial NCT02882048?

This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2016-09. Estimated completion is 2019-02-25.

What interventions are being tested in trial NCT02882048?

The interventions under investigation include: Medication management (OTHER), NADA Protocol (PROCEDURE).

Who is sponsoring clinical trial NCT02882048?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.